Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

Abstract

Aims Continuous subcutaneous insulin infusion (CSII) is a recommended treatment for reducing severe hypoglycaemia in Type 1 diabetes, but the change in hypoglycaemia compared with multiple daily insulin injections (MDI) is unclear. We therefore conducted a meta-analysis comparing severe hypoglycaemia and glycaemic control during CSII and MDI.Methods Databases and literature (1996 -2006) were searched for randomized controlled trials (RCTs) and before/after studies of ≥ 6 months' duration CSII and with severe hypoglycaemia frequency > 10 episodes/100 patient years on MDI.Results In 22 studies (21 reports), severe hypoglycaemia during MDI was related to diabetes duration ( P = 0.038) and was greater in adults than children (100 vs. 36 events/100 patient years, P = 0.036). Severe hypoglycaemia was reduced during CSII compared with MDI, with a rate ratio of 2.89 (95% CI 1.45 to 5.76) for RCTs and 4.34 (2.87 to 6.56) for before/after studies [rate ratio 4.19 (2.86 to 6.13) for all studies]. The reduction was greatest in those with the highest initial severe hypoglycaemia rates on MDI ( P < 0.001). The mean difference in glycated haemoglobin (HbA 1c ) between treatments was less for RCTs [0.21% (0.13-0.30%)] than in before/after studies [0.72% (0.55-0.90%)] but strongly related to the initial HbA 1c on MDI ( P < 0.001). ConclusionsThe severe hypoglycaemia rate in Type 1 diabetes was markedly less during CSII than MDI, with the greatest reduction in those with most severe hypoglycaemia on MDI and those with the longest duration of diabetes. The biggest improvement in HbA 1c was in those with the highest HbA 1c on MDI.Diabet. Med. 25, 765-774 (2008)

Individualism and insulin pump therapy

“…It uses a structured curriculum approach and covers all aspects of pump therapy, including the 'smart' features. Consistent with published data, we have found that the use of insulin pump therapy is associated with sustained improvements in HbA 1c levels, fewer hypoglycaemic episodes, enhanced early warning symptoms of impending low blood glucose levels and an improved quality of life [1][2][3][4].…”

High Reported Treatment Satisfaction in People With Type 1 Diabetes Switching to Latest Generation Insulin Pump Regardless of Previous Therapy

“…Treatment with insulin pumps has been shown to be an effective method for improving glycemic control and preventing/ delaying long-term diabetic complications, [1][2][3] and is the recommended therapy for most individuals with type 1 diabetes (T1D). 4 Use of insulin pumps in combination with continuous glucose monitoring (CGM) technologies has been shown to further improve clinical outcomes.…”

The poor children of the poor: Coping with diabetes control in a resource-poor setting

“…Several metaanalyses show a statistical difference in favour of pump therapy, but only amounting to a minimal improvement of 0.2 -0.3% in HbA1c values. [9][10][11][12] Similarly, continuous subcutaneous glucose sensing devices exist to improve blood glucose control, but again by a clinically unimportant amount. [13] It is gratifying that every one of our patients had access to a refrigerator.…”